Health, Medical & Pharma News - Updated Daily page 58

Sleep Deficiency Linked to Atrophy of the Inferior Parietal Region of the Brain

Sleep deficiency is associated with atrophy of the inferior parietal region of the brain, according to a study published online March 31 in the Journal of Clini

Weight Loss Greater With Intermittent Fasting Than Calorie Restriction

An intermittent fasting (IMF) intervention yields modestly greater weight loss than daily caloric restriction (DCR) among adults with overweight or obesity, acc

Ground Coffee Recalled in 15 States for Caffeine Labeling Error

The U.S. Food and Drug Administration (FDA) has recalled ground coffee sold in 15 states after finding it may have been wrongly labeled as decaffeinated. Hundre

Top FDA Vaccine Official Quits, Warns of Vaccine Misinformation

A top vaccine official at the U.S. Food and Drug Administration (FDA) is stepping down, warning that vaccine misinformation is coloring the country s top health

New Drug May Cut Sudden Heart Risk by 94%

A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the blood. The drug, made by Eli Lilly a

Evidence Supports Continuing Buprenorphine for Acute Pain in Those With Opioid Use Disorder

For patients with opioid use disorder (OUD), evidence supports continuation of buprenorphine during episodes of acute pain, but overall evidence for pain outcom

Guideline Adherence Suboptimal for Chlamydia, Gonorrhea Treatment

Across primary care practices, guideline adherence remains suboptimal for chlamydia and gonorrhea, according to a study published in the March April issue of th

Speed of Resuscitation Critical to Survival Outcomes After Cardiac Arrest Events

For patients with out-of-hospital cardiac arrest (OHCA), the proportion receiving layperson bystander life support (BLS) has increased, but a critical factor in

Low Creatinine-to-Cystatin C Ratio Tied to Lower Muscle Volume in Midlife Women

Among middle-aged women, low creatinine-to-cystatin C ratio (CCR) at baseline is associated with lower fat-free muscle volumes and poorer gait speeds 6.6 years

FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors

The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients with previously treated advanced ne

Pharmaceutical News and Articles